LEADER 04189nam 2200613 450 001 9910797922103321 005 20230803214015.0 010 $a90-04-28028-6 024 7 $a10.1163/9789004280281 035 $a(CKB)3710000000575571 035 $a(EBL)4355954 035 $a(SSID)ssj0001600925 035 $a(PQKBManifestationID)16307951 035 $a(PQKBTitleCode)TC0001600925 035 $a(PQKBWorkID)14388704 035 $a(PQKB)10054458 035 $a(MiAaPQ)EBC4355954 035 $a(OCoLC)880237899 035 $a(nllekb)BRILL9789004280281 035 $a(Au-PeEL)EBL4355954 035 $a(CaPaEBR)ebr11151498 035 $a(CaONFJC)MIL890892 035 $a(OCoLC)918997402 035 $a(EXLCZ)993710000000575571 100 $a20160215h20142014 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aEnvisioning islamic art and architecture $eessays in honor of Renata Holod /$fedited by David J. Roxburgh 210 1$aLeiden, Netherlands ;$aBoston, Massachusetts :$cBrill,$d2014. 210 4$d©2014 215 $a1 online resource (341 p.) 225 1 $aArts and Archaeology of the Islamic World,$x2213-3844 ;$vVolume 2 300 $aDescription based upon print version of record. 311 $a90-04-26402-7 320 $aIncludes bibliographical references and index. 327 $tPreliminary Material /$rDavid J. Roxburgh -- $tInventing the Alhambra /$rD. Fairchild Ruggles -- $tPower, Light, Intra-Confessional Discontent, and the Almoravids /$rCynthia Robinson -- $tMedieval Textiles in Iberia: Studies for a New Approach /$rMaría Judith Feliciano -- $tTelling Tales: Investigating a M?n??? Bowl /$rLeslee Katrina Michelsen and Johanna Olafsdotter -- $tSeeing the Light: Enacting the Divine at Three Medieval Syrian Shrines /$rStephennie Mulder -- $tPatterns of Faith: Mosque Typologies and Sectarian Affiliation in the Kingdom of Ahmadnagar /$rPushkar Sohoni -- $tSaints, Sam??, and the Politics of Charisma in Late-Nineteenth-Century Hyderabad, India /$rAlison Mackenzie Shah -- $tBetween the Brush and the Pen: On the Intertwined Histories of Mughal Painting and Calligraphy /$rYael Rice -- $t?Many a Wish Has Turned to Dust?: Pir Budaq and the Formation of Turkmen Arts of the Book /$rDavid J. Roxburgh -- $tThe Rose of the Prophet: Floral Metaphors in Late Ottoman Devotional Art /$rChristiane Gruber -- $tPicturing the ?Abode of Felicity? in 1919: A Photograph Album of Istanbul /$rNancy Micklewright -- $tBibliography /$rDavid J. Roxburgh -- $tIndex /$rDavid J. Roxburgh. 330 $aEnvisioning Islamic Art and Architecture: Essays in Honor of Renata Holod is a collection of studies on the portable arts, arts of the book, painting, photography, and architecture spanning the medieval and modern periods and across the historical Islamic lands. The essays reflect the wide-ranging interests and diverse methodologies of Renata Holod and attend to the physical, material, and aesthetic properties of their objects, offer nuanced explanations of complex relations between objects and historical contexts, and remain critically aware of the shape of the field of Islamic art and architecture, its canonical objects, approaches, and historiographies. Essential reading for scholars working on Islam and the Islamic world in the disciplines of history of art and architecture, history, literature, and anthropology. With contributions by María Judith Feliciano, Christiane Gruber, Leslee Katrina Michelsen, Nancy Micklewright, Stephennie Mulder, Johanna Olafsdotter, Yael Rice, Cynthia Robinson, David J. Roxburgh, D. Fairchild Ruggles, Alison Mackenzie Shah, and Pushkar Sohoni. 410 0$aArts and archaeology of the Islamic world ; Volume 2. 606 $aIslamic art 606 $aIslamic architecture 615 0$aIslamic art. 615 0$aIslamic architecture. 676 $a709.17/67 702 $aRoxburgh$b David J. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910797922103321 996 $aEnvisioning islamic art and architecture$93672239 997 $aUNINA LEADER 05360nam 22007335 450 001 9910298214803321 005 20210218120530.0 010 $a3-319-66833-1 024 7 $a10.1007/978-3-319-66833-8 035 $a(CKB)4100000004243459 035 $a(DE-He213)978-3-319-66833-8 035 $a(MiAaPQ)EBC5390258 035 $a(PPN)227405390 035 $a(EXLCZ)994100000004243459 100 $a20180510d2018 u| 0 101 0 $aeng 135 $aurnn#008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aLeading Pharmaceutical Innovation $eHow to Win the Life Science Race /$fby Oliver Gassmann, Alexander Schuhmacher, Max von Zedtwitz, Gerrit Reepmeyer 205 $a3rd ed. 2018. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2018. 215 $a1 online resource (XV, 179 p. 41 illus., 3 illus. in color.) 311 $a3-319-66832-3 327 $aInnovation: Key to Success in the Pharmaceutical Industry -- The Industry Challenge: Who Would Want to Be in This Business?- The Science and Technology Challenge: How to Find New Drugs -- The Pipeline Challenge: How to Organize Innovation -- The Make-or-Buy Challenge: How to In- and Outsource Innovation -- The Open Innovation Challenge: How to Partner for Innovation -- The Internationalization Challenge: Where to Access Innovation -- Future Directions and Trends. 330 $aThis book investigates and highlights the most critical challenges the pharmaceutical industry faces in an increasingly competitive environment of inflationary R&D investments and tightening cost control pressures. The authors present three sources of pharmaceutical innovation: new management methods in the drug development pipeline; new technologies as enablers for cutting-edge R&D; and new forms of cooperation and internationalization, such as open innovation in the early phases of R&D. New models and methods are illustrated with cases from Europe, the US, and Asia. This third fully revised edition was expanded to reflect the latest updates in open and collaborative innovation, the greater strategic importance of venture capital and early-stage investments, and the new range of emerging technologies now being put to use in pharmaceutical innovation. Health care innovation is possibly the greatest opportunity and challenge of our generation. This important book shows how pharmaceutical companies will continue to play an instrument role in making our lives better. Stefan Thomke, William Barclay Harding Professor of Business Administration, Harvard Business School Very comprehensive review and analysis of current challenges for the biopharmaceutical industry. To stay competitive in this new technology driven environment, the industry started to develop new partnership models to close the innovation gap and provide patients with the relevant healthcare toolkits at the convergence of pharmaceuticals, diagnostics and IT technologies. Very exciting times ahead well depicted in this book! Karima Boubekeur, VP Emerging Portfolio and Search & Evaluation, AstraZeneca Great. The 3rd edition is not only an update. It?s an outstandingly featured summary on the challenges of pharma innovation. Eckard von Keutz, SVP and Head of Early Development, Bayer Healthcare. 606 $aManagement 606 $aIndustrial management 606 $aPharmaceutical technology 606 $aPharmacy management 606 $aPharmacy 606 $aHealth care management 606 $aHealth services administration 606 $aHealth economics 606 $aInnovation/Technology Management$3https://scigraph.springernature.com/ontologies/product-market-codes/518000 606 $aPharmaceutical Sciences/Technology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21010 606 $aPharmacoeconomics and Health Outcomes$3https://scigraph.springernature.com/ontologies/product-market-codes/H69020 606 $aPharmacy$3https://scigraph.springernature.com/ontologies/product-market-codes/F00008 606 $aHealth Care Management$3https://scigraph.springernature.com/ontologies/product-market-codes/527030 606 $aHealth Economics$3https://scigraph.springernature.com/ontologies/product-market-codes/W35000 615 0$aManagement. 615 0$aIndustrial management. 615 0$aPharmaceutical technology. 615 0$aPharmacy management. 615 0$aPharmacy. 615 0$aHealth care management. 615 0$aHealth services administration. 615 0$aHealth economics. 615 14$aInnovation/Technology Management. 615 24$aPharmaceutical Sciences/Technology. 615 24$aPharmacoeconomics and Health Outcomes. 615 24$aPharmacy. 615 24$aHealth Care Management. 615 24$aHealth Economics. 676 $a658.514 700 $aGassmann$b Oliver$4aut$4http://id.loc.gov/vocabulary/relators/aut$0147678 702 $aSchuhmacher$b Alexander$4aut$4http://id.loc.gov/vocabulary/relators/aut 702 $avon Zedtwitz$b Max$4aut$4http://id.loc.gov/vocabulary/relators/aut 702 $aReepmeyer$b Gerrit$4aut$4http://id.loc.gov/vocabulary/relators/aut 906 $aBOOK 912 $a9910298214803321 996 $aLeading Pharmaceutical Innovation$92526800 997 $aUNINA LEADER 03678nam 22005055 450 001 9910484778303321 005 20200711000134.0 010 $a3-662-49527-9 024 7 $a10.1007/978-3-662-49527-8 035 $a(CKB)3710000000847023 035 $a(EBL)4671061 035 $a(DE-He213)978-3-662-49527-8 035 $a(MiAaPQ)EBC4671061 035 $a(PPN)195508254 035 $a(EXLCZ)993710000000847023 100 $a20160902d2017 u| 0 101 0 $ager 135 $aur|n|---||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aPatentmanagement $eInnovationen erfolgreich nutzen und schützen /$fvon Oliver Gassmann, Martin A. Bader 205 $a4th ed. 2017. 210 1$aBerlin, Heidelberg :$cSpringer Berlin Heidelberg :$cImprint: Springer Gabler,$d2017. 215 $a1 online resource (313 p.) 300 $aDescription based upon print version of record. 311 $a3-662-49526-0 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aGrundlagen von gewerblichen Schutzrechten -- Generierung, Bewertung und Verwertung von Patenten -- Prozesse des Patentmanagements -- Organisation des Patentmanagements -- Branchen- und Länderspezifika -- Zahlreiche Praxis- und Fallbeispiele erfolgreicher Unternehmen. 330 $aDieses Buch bietet einen Überblick über gängige Konzepte und Bausteine des Patentmanagements. Es wendet sich an Führungskräfte in den Bereichen Innovation, F&E und Patentmanagement sowie Wissenschaftler und Studierende. Basierend auf der Zusammenarbeit mit bzw. einer Analyse von mehr als 350 technologieintensiven Unternehmen aus Europa, den USA, China, Taiwan, Japan, Südkorea, Brasilien und Indien liefert es wertvolle Informationen zu den Ausprägungen des Patentmanagements. Die 4. Auflage wurde vollständig überarbeitet, aktualisiert und erweitert. Der Inhalt: Grundlagen von gewerblichen Schutzrechten.- Generierung, Bewertung und Verwertung von Patenten.- Prozesse des Patentmanagements.- Organisation des Patentmanagements.- Branchen- und Länderspezifika.- Zahlreiche Praxis- und Fallbeispiele erfolgreicher Unternehmen. Die Autoren: Prof. Dr. Oliver Gassmann ist Professor für Innovationsmanagement und Direktionsvorsitzender des Instituts für Technologiemanagement an der Universität St. Gallen. Er ist Autor zahlreicher Bücher und berät einige Fortune 500 Unternehmen in Innovation und Unternehmensentwicklung. Prof. Dr. Martin A. Bader ist Professor für Technologiemanagement und Entrepreneurship an der Technischen Hochschule Ingolstadt sowie Patentanwalt und Partner der BGW AG Management Advisory Group, einem auf Innovations- und Intellectual Property Management Beratung spezialisierten Spin-Off der Universität St. Gallen. Er gehört zum Kreis der weltweit Top-300 IP-Strategieberater und ist Mediator für das WIPO Arbitration and Mediation Center. 606 $aManagement 606 $aIndustrial management 606 $aManagement$3https://scigraph.springernature.com/ontologies/product-market-codes/515000 606 $aInnovation/Technology Management$3https://scigraph.springernature.com/ontologies/product-market-codes/518000 615 0$aManagement. 615 0$aIndustrial management. 615 14$aManagement. 615 24$aInnovation/Technology Management. 676 $a650 700 $aGassmann$b Oliver$4aut$4http://id.loc.gov/vocabulary/relators/aut$0147678 702 $aBader$b Martin A$4aut$4http://id.loc.gov/vocabulary/relators/aut 906 $aBOOK 912 $a9910484778303321 996 $aPatentmanagement$92849835 997 $aUNINA